|
DPM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29816166097407E-14 |
| Normal-vs-Stage2 |
2.22549978445841E-10 |
| Normal-vs-Stage3 |
1.88848936488739E-13 |
| Normal-vs-Stage4 |
1.63224989080391E-12 |
| Stage1-vs-Stage2 |
1.447980E-01 |
| Stage1-vs-Stage3 |
3.431600E-01 |
| Stage1-vs-Stage4 |
7.275500E-03 |
| Stage2-vs-Stage3 |
4.867000E-01 |
| Stage2-vs-Stage4 |
3.933600E-01 |
| Stage3-vs-Stage4 |
6.781700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.88040999999917E-05 |
| Normal-vs-Asian |
1.81189996339981E-09 |
| Caucasian-vs-AfricanAmerican |
3.024800E-01 |
| Caucasian-vs-Asian |
6.441200E-01 |
| AfricanAmerican-vs-Asian |
5.461800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.63535851527286E-12 |
| Male-vs-Female |
6.578200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.02577970959328E-12 |
| Normal-vs-Age(41-60Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(61-80Yrs) |
1.67010849594362E-12 |
| Normal-vs-Age(81-100Yrs) |
6.859400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.412400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.284100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.706400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.322600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.697400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.193200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.554000E-01 |
| Classical-VS-Follicular |
9.087400E-01 |
| Classical-VS-Other |
4.704600E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
5.916000E-01 |
| Tall-VS-Other |
7.535400E-01 |
| Tall-VS-Normal |
5.1040000004221E-09 |
| Follicular-VS-Other |
6.535800E-01 |
| Follicular-VS-Normal |
3.40390005071356E-09 |
| Other-VS-Normal |
5.201600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.530509218308E-14 |
| Normal-vs-N1 |
1.10300002464925E-09 |
| N0-vs-N1 |
7.452000E-01 |
|
|
